CLINICAL_TRIALS
trial_result
· 2014-03-18
Clinical Trial Update: Open-label Study of Safety and Tolerability of Memantine in Children With Autism [Phase 2]
Summary
Open-label Phase 2 study evaluating safety and tolerability of memantine in children with autism; completed with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Forest Laboratories | Conditions: Autism, Pediatric Autism | Phase 2 | Status: COMPLETED | Results posted: 2014-03-18